{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T15:59:24Z","timestamp":1785340764195,"version":"3.55.0"},"reference-count":177,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T00:00:00Z","timestamp":1740268800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100020582","name":"National Institute of Pharmaceutical Education and Research, Raebareli","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020582","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014824","name":"Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014824","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ajps.2025.101040","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T19:22:46Z","timestamp":1740597766000},"page":"101040","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Navigating the brain: Harnessing endogenous cellular hitchhiking for targeting neoplastic and neuroinflammatory diseases"],"prefix":"10.1016","volume":"20","author":[{"given":"Suraj S.","family":"Wagh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paras","family":"Famta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh","family":"Vambhurkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giriraj","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupama","family":"Sikder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurpreet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalini","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajja Bhanu","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshay","family":"Shinde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin Pal","family":"Kalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev Singh","family":"Raghuvanshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajps.2025.101040_bib0001","article-title":"Neutrophil hitchhiking for nanoparticle delivery to the central nervous system","volume":"38","author":"Liu","year":"2024","journal-title":"Appl Mater Today"},{"key":"10.1016\/j.ajps.2025.101040_bib0002","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.gendis.2021.09.006","article-title":"Inflammation and cancer: paradoxical roles in tumorigenesis and implications in immunotherapies","volume":"10","author":"Liu","year":"2023","journal-title":"Genes Dis"},{"key":"10.1016\/j.ajps.2025.101040_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinme.2024.100015","article-title":"Emerging therapies and respiratory infections: focus on the impact of immunosuppressants and immunotherapies","volume":"24","author":"Patterson","year":"2024","journal-title":"Clinical Medicine"},{"key":"10.1016\/j.ajps.2025.101040_bib0004","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1021\/acschemneuro.0c00427","article-title":"Neuroinflammation mechanisms and phytotherapeutic intervention: a systematic review","volume":"11","author":"Kaur","year":"2020","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.ajps.2025.101040_bib0005","doi-asserted-by":"crossref","first-page":"e1132","DOI":"10.1038\/tp.2017.76","article-title":"Immunological effects of behavioral activation with exercise in major depression: an exploratory randomized controlled trial","volume":"7","author":"Euteneuer","year":"2017","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.ajps.2025.101040_bib0006","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3389\/fncel.2015.00322","article-title":"Ros-Bernal F. Implications of glial nitric oxide in neurodegenerative diseases","volume":"9","author":"Yuste","year":"2015","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.ajps.2025.101040_bib0007","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ijpharm.2017.07.049","article-title":"Breaching barriers in glioblastoma. Part II: targeted drug delivery and lipid nanoparticles","volume":"531","author":"Miranda","year":"2017","journal-title":"Int J Pharm"},{"key":"10.1016\/j.ajps.2025.101040_bib0008","article-title":"Deciphering convection enhanced delivery: a paradigm shift for circumventing glioblastoma multiforme","volume":"103","author":"Sikder","year":"2025","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.ajps.2025.101040_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105780","article-title":"Glioblastoma multiforme (GBM): an overview of current therapies and mechanisms of resistance","volume":"171","author":"Wu","year":"2021","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.ajps.2025.101040_bib0010","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s13148-021-01139-w","article-title":"Chromatin insulation dynamics in glioblastoma: challenges and future perspectives of precision oncology","volume":"13","author":"Ses\u00e9","year":"2021","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.ajps.2025.101040_bib0011","doi-asserted-by":"crossref","first-page":"16359","DOI":"10.1021\/acsnano.4c01790","article-title":"Peptide-hitchhiking for the development of nanosystems in glioblastoma","volume":"18","author":"Branco","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.ajps.2025.101040_bib0012","doi-asserted-by":"crossref","first-page":"5354","DOI":"10.3390\/jcm11185354","article-title":"Surgical treatment of glioblastoma: state-of-the-art and future trends","volume":"11","author":"Sales","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.ajps.2025.101040_bib0013","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.3390\/biomedicines9121834","article-title":"Drug delivery challenges in brain disorders across the blood\u2013brain barrier: novel methods and future considerations for improved therapy","volume":"9","author":"Achar","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.ajps.2025.101040_bib0014","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.3390\/pharmaceutics15122658","article-title":"Drug delivery to the brain: recent advances and unmet challenges","volume":"15","author":"Bhunia","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ajps.2025.101040_bib0015","article-title":"Progress and perspectives on nanoplatforms for drug delivery to the brain","volume":"57","author":"Xu","year":"2020","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.ajps.2025.101040_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.adcanc.2022.100083","article-title":"Nanovesicles based drug targeting to control tumor growth and metastasis","volume":"7","author":"Ansari","year":"2023","journal-title":"Adv Cancer Biol - Metastasis"},{"key":"10.1016\/j.ajps.2025.101040_bib0017","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.immuni.2022.12.008","article-title":"Microenvironment-driven metabolic adaptations guiding CD8+ T cell anti-tumor immunity","volume":"56","author":"Park","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.ajps.2025.101040_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.onano.2023.100184","article-title":"Research progress of nanomaterials in tumor-targeted drug delivery and imaging therapy","volume":"14","author":"Fang","year":"2023","journal-title":"OpenNano"},{"key":"10.1016\/j.ajps.2025.101040_bib0019","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1039\/D2BM01833K","article-title":"Reactive oxygen species-upregulating nanomedicines towards enhanced cancer therapy","volume":"11","author":"Ding","year":"2023","journal-title":"Biomater Sci"},{"issue":"1","key":"10.1016\/j.ajps.2025.101040_bib0020","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2023.2183815","article-title":"A detailed insight of the tumor targeting using nanocarrier drug delivery system","volume":"30","author":"Batool","year":"2023","journal-title":"Drug Deliv"},{"key":"10.1016\/j.ajps.2025.101040_bib0021","first-page":"69","article-title":"Macrophage membrane-coated nanovesicles for dual-targeted drug delivery to inhibit tumor and induce macrophage polarization","volume":"23","author":"Huang","year":"2023","journal-title":"Bioact Mater"},{"key":"10.1016\/j.ajps.2025.101040_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfa.2023.131709","article-title":"Cooperative interaction of a highly hydrophilic pluronic with bile salts of different hydrophobicity","volume":"672","author":"Wagh","year":"2023","journal-title":"Colloids Surf A Physicochem Eng Asp"},{"issue":"19","key":"10.1016\/j.ajps.2025.101040_bib0023","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201704307","article-title":"Biodistribution, clearance, and long-term fate of clinically relevant nanomaterials","volume":"30","author":"Bourquin","year":"2018","journal-title":"Advanced Materials"},{"key":"10.1016\/j.ajps.2025.101040_bib0024","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.2147\/IJN.S42511","article-title":"Effects of nanoencapsulation and PEGylation on biodistribution of indocyanine green in healthy mice: quantitative fluorescence imaging and analysis of organs","volume":"8","author":"Anvari","year":"2013","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.ajps.2025.101040_bib0025","doi-asserted-by":"crossref","first-page":"23410","DOI":"10.1021\/acsami.1c02834","article-title":"Innate immune invisible ultrasmall gold nanoparticles\u2014framework for synthesis and evaluation","volume":"13","author":"Zhu","year":"2021","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.ajps.2025.101040_bib0026","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.actbio.2022.11.001","article-title":"Immune cell\u2013camouflaged surface-engineered nanotherapeutics for cancer management","volume":"155","author":"Jain","year":"2023","journal-title":"Acta Biomater"},{"key":"10.1016\/j.ajps.2025.101040_bib0027","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.2165\/11207510-000000000-00000","article-title":"Pegylated liposomal doxorubicin","volume":"71","author":"Duggan","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.ajps.2025.101040_bib0028","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.addr.2020.07.024","article-title":"Anti-PEG antibodies: properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals","volume":"154\u2013155","author":"Kozma","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.ajps.2025.101040_bib0029","doi-asserted-by":"crossref","first-page":"236","DOI":"10.7150\/ntno.77564","article-title":"Natural and synthetic nanovectors for cancer therapy","volume":"7","author":"Eftekhari","year":"2023","journal-title":"Nanotheranostics"},{"key":"10.1016\/j.ajps.2025.101040_bib0030","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s13346-024-01669-9","article-title":"Amelioration of breast cancer therapies through normalization of tumor vessels and microenvironment: paradigm shift to improve drug perfusion and nanocarrier permeation","volume":"15","author":"Famta","year":"2025","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.ajps.2025.101040_bib0031","doi-asserted-by":"crossref","first-page":"5052","DOI":"10.3390\/molecules26165052","article-title":"Advances in biomimetic nanoparticles for targeted cancer therapy and diagnosis","volume":"26","author":"Beh","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ajps.2025.101040_bib0032","doi-asserted-by":"crossref","first-page":"8423","DOI":"10.1021\/acsnano.8b03900","article-title":"Quantifying the ligand-coated nanoparticle delivery to cancer cells in solid tumors","volume":"12","author":"Dai","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.ajps.2025.101040_bib0033","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ajps.2025.101040_bib0034","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1080\/03639045.2025.2453533","article-title":"Docetaxel and niclosamide-loaded nanofiber systems for improved chemo-therapeutic activity and resistance reversal in prostate cancer","volume":"51","author":"Shah","year":"2025","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.ajps.2025.101040_bib0035","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s12668-025-01833-6","article-title":"QbD manoeuvred niclosamide laden polylactic-co-glycolic acid nanoparticles-impregnated gelatin nanofibers for the management of oral carcinoma","volume":"15","author":"Shah","year":"2025","journal-title":"Bionanoscience"},{"key":"10.1016\/j.ajps.2025.101040_bib0036","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jconrel.2017.03.035","article-title":"Tumortropic adipose-derived stem cells carrying smart nanotherapeutics for targeted delivery and dual-modality therapy of orthotopic glioblastoma","volume":"254","author":"Huang","year":"2017","journal-title":"J Controlled Rel"},{"key":"10.1016\/j.ajps.2025.101040_bib0037","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.mattod.2015.11.025","article-title":"Tumor microenvironment and intracellular signal-activated nanomaterials for anticancer drug delivery","volume":"19","author":"Mo","year":"2016","journal-title":"Mater Today"},{"key":"10.1016\/j.ajps.2025.101040_bib0038","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2015.07.043","article-title":"Exploiting shape, cellular-hitchhiking and antibodies to target nanoparticles to lung endothelium: synergy between physical, chemical and biological approaches","volume":"68","author":"Anselmo","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.ajps.2025.101040_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115143","article-title":"In situ cellular hitchhiking of nanoparticles for drug delivery","volume":"204","author":"Udofa","year":"2024","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.ajps.2025.101040_bib0040","doi-asserted-by":"crossref","first-page":"6399","DOI":"10.1039\/D2CS00968D","article-title":"Immunological nanomaterials to combat cancer metastasis","volume":"53","author":"Pan","year":"2024","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.ajps.2025.101040_bib0041","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.7150\/thno.88002","article-title":"Advanced hitchhiking nanomaterials for biomedical applications","volume":"13","author":"Wang","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.ajps.2025.101040_bib0042","doi-asserted-by":"crossref","first-page":"13333","DOI":"10.1021\/acsnano.3c01428","article-title":"Nanoparticles hitchhike on monocytes for glioblastoma treatment after low-dose radiotherapy","volume":"17","author":"Kuang","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.ajps.2025.101040_bib0043","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202301348","article-title":"Ligustrazine nanoparticle hitchhiking on neutrophils for enhanced therapy of cerebral ischemia-reperfusion injury","volume":"10","author":"Mu","year":"2023","journal-title":"Adv Sci"},{"key":"10.1016\/j.ajps.2025.101040_bib0044","doi-asserted-by":"crossref","first-page":"11129","DOI":"10.1021\/nn404853z","article-title":"Delivering nanoparticles to lungs while avoiding liver and spleen through adsorption on red blood cells","volume":"7","author":"Anselmo","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.ajps.2025.101040_bib0045","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrc.2016.108","article-title":"Cancer nanomedicine: progress, challenges and opportunities","volume":"17","author":"Shi","year":"2017","journal-title":"Nat Rev Cancer"},{"issue":"15","key":"10.1016\/j.ajps.2025.101040_bib0046","article-title":"Engineering cell membrane-based nanotherapeutics to target inflammation","volume":"6","author":"Yan","year":"2019","journal-title":"Adv Sci"},{"key":"10.1016\/j.ajps.2025.101040_bib0047","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.biopsych.2013.10.014","article-title":"Immune activation promotes depression 1 month after diffuse brain injury: A role for primed microglia","volume":"76","author":"Fenn","year":"2014","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.ajps.2025.101040_bib0048","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.pneurobio.2015.05.003","article-title":"Alternatively activated microglia and macrophages in the central nervous system","volume":"131","author":"Franco","year":"2015","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.ajps.2025.101040_bib0049","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jocn.2009.05.006","article-title":"The role of microglia in central nervous system immunity and glioma immunology","volume":"17","author":"Yang","year":"2010","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.ajps.2025.101040_bib0050","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/glia.20928","article-title":"Innate immunity and neuroinflammation in the CNS: the role of microglia in toll-like receptor-mediated neuronal injury","volume":"58","author":"Lehnardt","year":"2010","journal-title":"Glia"},{"key":"10.1016\/j.ajps.2025.101040_bib0051","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1517\/17425255.4.10.1265","article-title":"Neuroinflammation and microglia: considerations and approaches for neurotoxicity assessment","volume":"4","author":"Harry","year":"2008","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.ajps.2025.101040_bib0052","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.biomaterials.2017.06.017","article-title":"Macrophages with cellular backpacks for targeted drug delivery to the brain","volume":"140","author":"Klyachko","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.ajps.2025.101040_bib0053","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106218","article-title":"Recent advances in glioma microenvironment-response nanoplatforms for phototherapy and sonotherapy","volume":"179","author":"Li","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.ajps.2025.101040_bib0054","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12951-021-01220-9","article-title":"A novel therapeutic strategy of multimodal nanoconjugates for state-of-the-art brain tumor phototherapy","volume":"20","author":"Kim","year":"2022","journal-title":"J Nanobiotechnology"},{"issue":"23","key":"10.1016\/j.ajps.2025.101040_bib0055","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202402516","article-title":"Carrier-free self-assembly nano-sonosensitizers for sonodynamic-amplified cuproptosis-ferroptosis in glioblastoma therapy","volume":"11","author":"Zhu","year":"2024","journal-title":"Advanced Science"},{"key":"10.1016\/j.ajps.2025.101040_bib0056","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.actbio.2024.07.017","article-title":"Metal-polyphenol self-assembled nanodots for NIR-II fluorescence imaging-guided chemodynamic\/photodynamic therapy-amplified ferroptosis","volume":"185","author":"Zhu","year":"2024","journal-title":"Acta Biomater"},{"key":"10.1016\/j.ajps.2025.101040_bib0057","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3390\/cells10010100","article-title":"Inflammatory cytokines in cancer: comprehensive understanding and clinical progress in gene therapy","volume":"10","author":"Lan","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ajps.2025.101040_bib0058","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nri.2017.49","article-title":"Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy","volume":"17","author":"Nagarsheth","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ajps.2025.101040_bib0059","doi-asserted-by":"crossref","first-page":"R1001","DOI":"10.1186\/ar1776","article-title":"Differential expression of chemokine receptors on peripheral blood B cells from patients with rheumatoid arthritis and systemic lupus erythematosus","volume":"7","author":"Henneken","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ajps.2025.101040_bib0060","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1158\/0008-5472.CAN-09-3642","article-title":"The chemokine receptor CXCR7 is highly expressed in human glioma cells and mediates antiapoptotic effects","volume":"70","author":"Hattermann","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajps.2025.101040_bib0061","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ajps.2025.101040_bib0062","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nri3070","article-title":"Monocyte recruitment during infection and inflammation","volume":"11","author":"Shi","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ajps.2025.101040_bib0063","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1172\/JCI84427","article-title":"The impact of hypoxia on tumor-associated macrophages","volume":"126","author":"Henze","year":"2016","journal-title":"J Clin Investigat"},{"key":"10.1016\/j.ajps.2025.101040_bib0064","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1021\/ab500179h","article-title":"Design strategies and applications of circulating cell-mediated drug delivery systems","volume":"1","author":"Su","year":"2015","journal-title":"ACS Biomater Sci Eng"},{"key":"10.1016\/j.ajps.2025.101040_bib0065","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1517\/17425247.2011.559457","article-title":"Cell-mediated drug delivery","volume":"8","author":"Batrakova","year":"2011","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.ajps.2025.101040_bib0066","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jconrel.2014.03.050","article-title":"Cell-mediated delivery of nanoparticles: taking advantage of circulatory cells to target nanoparticles","volume":"190","author":"Anselmo","year":"2014","journal-title":"J Controll Rel"},{"key":"10.1016\/j.ajps.2025.101040_bib0067","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12967-021-02822-5","article-title":"Chemokines and their receptors: predictors of the therapeutic potential of mesenchymal stromal cells","volume":"19","author":"Cuesta-Gomez","year":"2021","journal-title":"J Transl Med"},{"key":"10.1016\/j.ajps.2025.101040_bib0068","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.796111","article-title":"Human mesenchymal stem cells as a carrier for a cell-mediated drug delivery","volume":"10","author":"Litvinova","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.ajps.2025.101040_bib0069","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1002\/bit.25307","article-title":"Co-opting biology to deliver drugs","volume":"111","author":"Yousefpour","year":"2014","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.ajps.2025.101040_bib0070","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1182\/blood-2017-05-743187","article-title":"Cancer and platelet crosstalk: opportunities and challenges for aspirin and other antiplatelet agents","volume":"131","author":"Xu","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.ajps.2025.101040_bib0071","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1158\/0008-5472.CAN-19-1181","article-title":"The interaction of platelets with colorectal cancer cells inhibits tumor growth but promotes metastasis","volume":"80","author":"Plantureux","year":"2020","journal-title":"Cancer Res"},{"issue":"30","key":"10.1016\/j.ajps.2025.101040_bib0072","doi-asserted-by":"crossref","first-page":"E3053","DOI":"10.1073\/pnas.1411082111","article-title":"Platelets guide the formation of early metastatic niches","volume":"111","author":"Labelle","year":"2014","journal-title":"Proceed Natl Acad Sci"},{"key":"10.1016\/j.ajps.2025.101040_bib0073","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.3892\/mmr.2016.4948","article-title":"Role of neuroinflammation in neurodegenerative diseases (Review)","volume":"13","author":"Chen","year":"2016","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.ajps.2025.101040_bib0074","doi-asserted-by":"crossref","DOI":"10.1177\/2398212819901082","article-title":"The role of the immune system in driving neuroinflammation","volume":"4","author":"N\u00ed Chasaide","year":"2020","journal-title":"Brain Neurosci Adv"},{"key":"10.1016\/j.ajps.2025.101040_bib0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.conb.2019.11.009","article-title":"The microbiome-gut-brain axis in acute and chronic brain diseases","volume":"61","author":"Benakis","year":"2020","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.ajps.2025.101040_bib0076","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1212\/WNL.0000000000004411","article-title":"Neuroinflammation drives anxiety and depression in relapsing-remitting multiple sclerosis","volume":"89","author":"Rossi","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.ajps.2025.101040_bib0077","doi-asserted-by":"crossref","first-page":"H1","DOI":"10.1530\/VB-19-0033","article-title":"Immune cell trafficking across the blood-brain barrier in the absence and presence of neuroinflammation","volume":"2","author":"Marchetti","year":"2020","journal-title":"Vasc Biol"},{"key":"10.1016\/j.ajps.2025.101040_bib0078","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/ejn.14720","article-title":"Neuroinflammation and depression: a review","volume":"53","author":"Troubat","year":"2021","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.ajps.2025.101040_bib0079","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008260","article-title":"Japanese encephalitis virus and its mechanisms of neuroinvasion","volume":"16","author":"Hsieh","year":"2020","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ajps.2025.101040_bib0080","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3390\/children7110210","article-title":"Acute disseminated encephalomyelitis: current perspectives","volume":"7","author":"Paolilo","year":"2020","journal-title":"Children"},{"key":"10.1016\/j.ajps.2025.101040_bib0081","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000515594","article-title":"Neuroinflammation in mood disorders: role of regulatory immune cells","volume":"28","author":"Bauer","year":"2021","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.ajps.2025.101040_bib0082","article-title":"Targeted drug delivery systems to control neuroinflammation in central nervous system disorders","volume":"66","author":"Mozafari","year":"2021","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.ajps.2025.101040_bib0083","doi-asserted-by":"crossref","first-page":"6385","DOI":"10.3390\/ijms22126385","article-title":"Molecular mechanisms of drug resistance in glioblastoma","volume":"22","author":"Dymova","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajps.2025.101040_bib0084","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41572-024-00516-y","article-title":"Glioma","volume":"10","author":"Weller","year":"2024","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.ajps.2025.101040_bib0085","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/neuonc\/nou324","article-title":"Glioma-derived versican promotes tumor expansion via glioma-associated microglial\/macrophages toll-like receptor 2 signaling","volume":"17","author":"Hu","year":"2015","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ajps.2025.101040_bib0086","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1093\/neuonc\/noz105","article-title":"Targeting the PI3K\/akt\/mTOR pathway with the pan-akt inhibitor GDC-0068 in PIK3CA-mutant breast cancer brain metastases","volume":"21","author":"Ippen","year":"2019","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ajps.2025.101040_bib0087","doi-asserted-by":"crossref","first-page":"e72079","DOI":"10.1371\/journal.pone.0072079","article-title":"Oleanolic acid suppresses migration and invasion of malignant glioma cells by inactivating MAPK\/ERK signaling pathway","volume":"8","author":"Guo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ajps.2025.101040_bib0088","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa5447","article-title":"Active targeting of chemotherapy to disseminated tumors using nanoparticle-carrying T cells","volume":"7","author":"Huang","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ajps.2025.101040_bib0089","doi-asserted-by":"crossref","first-page":"7832","DOI":"10.1021\/acsnano.9b08693","article-title":"Tumor targeting by \u03b1v\u03b23-integrin-specific lipid nanoparticles occurs via phagocyte hitchhiking","volume":"14","author":"Sofias","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.ajps.2025.101040_bib0090","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/cbf.3880","article-title":"Evasion of opsonization of macromolecules using novel surface-modification and biological-camouflage-mediated techniques for next-generation drug delivery","volume":"41","author":"Mehta","year":"2023","journal-title":"Cell Biochem Funct"},{"key":"10.1016\/j.ajps.2025.101040_bib0091","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/17425247.2016.1213238","article-title":"Surface functionalization of polymeric nanoparticles for tumor drug delivery: approaches and challenges","volume":"14","author":"Abd Ellah","year":"2017","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.ajps.2025.101040_bib0092","first-page":"35","article-title":"Engineering nanoparticles to overcome immunological barriers for enhanced drug delivery","volume":"1","author":"Malachowski","year":"2020","journal-title":"Engine Regener"},{"key":"10.1016\/j.ajps.2025.101040_bib0093","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/btm2.10005","article-title":"Engineering nanoparticles to overcome barriers to immunotherapy","volume":"1","author":"Toy","year":"2016","journal-title":"Bioeng Transl Med"},{"key":"10.1016\/j.ajps.2025.101040_bib0094","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1039\/D1BM01664D","article-title":"Macrophage membrane coated nanoparticles: a biomimetic approach for enhanced and targeted delivery","volume":"10","author":"Khatoon","year":"2022","journal-title":"Biomater Sci"},{"key":"10.1016\/j.ajps.2025.101040_bib0095","doi-asserted-by":"crossref","first-page":"26269","DOI":"10.1038\/srep26269","article-title":"Surface modification of nanoparticles enables selective evasion of phagocytic clearance by distinct macrophage phenotypes","volume":"6","author":"Qie","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajps.2025.101040_bib0096","doi-asserted-by":"crossref","first-page":"962","DOI":"10.7150\/thno.19061","article-title":"Development of sialic acid-coated nanoparticles for targeting cancer and efficient evasion of the immune system","volume":"7","author":"Kim","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.ajps.2025.101040_bib0097","doi-asserted-by":"crossref","first-page":"36910","DOI":"10.1039\/C6RA00398B","article-title":"Nanoparticles and mesenchymal stem cells: a win-win alliance for anticancer drug delivery","volume":"6","author":"Li","year":"2016","journal-title":"RSC Adv"},{"key":"10.1016\/j.ajps.2025.101040_bib0098","doi-asserted-by":"crossref","DOI":"10.1016\/j.medidd.2021.100119","article-title":"Blood cells as supercarrier systems for advanced drug delivery","volume":"13","author":"Wang","year":"2022","journal-title":"Med Drug Discov"},{"key":"10.1016\/j.ajps.2025.101040_bib0099","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1021\/jacsau.2c00247","article-title":"Macrophage-encapsulated bioorthogonal nanozymes for targeting cancer cells","volume":"2","author":"Das","year":"2022","journal-title":"JACS Au"},{"key":"10.1016\/j.ajps.2025.101040_bib0100","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1039\/D1NH00291K","article-title":"Macrophage-hitchhiking supramolecular aggregates of CuS nanoparticles for enhanced tumor deposition and photothermal therapy","volume":"6","author":"Li","year":"2021","journal-title":"Nanoscale Horiz"},{"issue":"34","key":"10.1016\/j.ajps.2025.101040_bib0101","article-title":"Macrophage hitchhiking nanoparticles for the treatment of myocardial infarction: an in vitro and in vivo study","volume":"33","author":"Torrieri","year":"2023","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.ajps.2025.101040_bib0102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/727241","article-title":"Targeted liposomal drug delivery to monocytes and macrophages","volume":"2011","author":"Kelly","year":"2011","journal-title":"J Drug Deliv"},{"key":"10.1016\/j.ajps.2025.101040_bib0103","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1016\/j.biomaterials.2012.02.022","article-title":"Use of macrophages to deliver therapeutic and imaging contrast agents to tumors","volume":"33","author":"Choi","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.ajps.2025.101040_bib0104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43556-020-00019-8","article-title":"Nose to brain delivery of antiretroviral drugs in the treatment of neuroAIDS","volume":"1","author":"Sarma","year":"2020","journal-title":"Molec Biomed"},{"key":"10.1016\/j.ajps.2025.101040_bib0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-60684-1","article-title":"Novel elvitegravir nanoformulation for drug delivery across the blood-brain barrier to achieve HIV-1 suppression in the CNS macrophages","volume":"10","author":"Gong","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajps.2025.101040_bib0106","doi-asserted-by":"crossref","first-page":"661","DOI":"10.4049\/jimmunol.0900274","article-title":"Macrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroAIDS","volume":"183","author":"Dou","year":"2009","journal-title":"J Immuno"},{"key":"10.1016\/j.ajps.2025.101040_bib0107","doi-asserted-by":"crossref","first-page":"21730","DOI":"10.1021\/jacs.0c09390","article-title":"Targeting microglia for therapy of parkinson's disease by using biomimetic ultrasmall nanoparticles","volume":"142","author":"Liu","year":"2020","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.ajps.2025.101040_bib0108","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.3390\/cells11121933","article-title":"Using extracellular vesicles released by GDNF-transfected macrophages for therapy of parkinson disease","volume":"11","author":"Zhao","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ajps.2025.101040_bib0109","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1080\/10717544.2018.1502839","article-title":"Primary M1 macrophages as multifunctional carrier combined with PLGA nanoparticle delivering anticancer drug for efficient glioma therapy","volume":"25","author":"Pang","year":"2018","journal-title":"Drug Deliv"},{"key":"10.1016\/j.ajps.2025.101040_bib0110","doi-asserted-by":"crossref","first-page":"5546","DOI":"10.1021\/acs.nanolett.7b02330","article-title":"Inflammatory monocytes loading protease-sensitive nanoparticles enable lung metastasis targeting and intelligent drug release for anti-metastasis therapy","volume":"17","author":"He","year":"2017","journal-title":"Nano Lett"},{"key":"10.1016\/j.ajps.2025.101040_bib0111","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.1021\/acsnano.2c11965","article-title":"Advances in drug delivery systems based on red blood cells and their membrane-derived nanoparticles","volume":"17","author":"Nguyen","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.ajps.2025.101040_bib0112","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1093\/neuonc\/noac071","article-title":"Blood exosomes-based targeted delivery of cPLA2 siRNA and metformin to modulate glioblastoma energy metabolism for tailoring personalized therapy","volume":"24","author":"Zhan","year":"2022","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ajps.2025.101040_bib0113","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.102037","article-title":"Immunoregulatory liposomes hitchhiking on neutrophils for enhanced carbon ion radiotherapy-assisted immunotherapy of glioblastoma","volume":"53","author":"Liu","year":"2023","journal-title":"Nano Today"},{"key":"10.1016\/j.ajps.2025.101040_bib0114","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1186\/s12951-022-01544-0","article-title":"Modularity of RBC hitchhiking with polymeric nanoparticles: testing the limits of non-covalent adsorption","volume":"20","author":"Lenders","year":"2022","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.ajps.2025.101040_bib0115","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jconrel.2004.08.005","article-title":"Prolonged circulation of large polymeric nanoparticles by non-covalent adsorption on erythrocytes","volume":"100","author":"Chambers","year":"2004","journal-title":"J Controlled Rel"},{"key":"10.1016\/j.ajps.2025.101040_bib0116","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1021\/nn506929e","article-title":"Monoclonal antibody-functionalized multilayered particles: targeting cancer cells in the presence of protein coronas","volume":"9","author":"Dai","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.ajps.2025.101040_bib0117","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/B978-0-12-420138-5.00010-0","article-title":"Quantitative deconvolution microscopy","volume":"123","author":"Goodwin","year":"2014","journal-title":"Methods Cell Biol"},{"key":"10.1016\/j.ajps.2025.101040_bib0118","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114394","article-title":"Cell-based drug delivery systems and their in vivo fate","volume":"187","author":"Yang","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"10.1016\/j.ajps.2025.101040_bib0119","first-page":"9","article-title":"Comparison of the usefulness of MTT and CellTiterGlo tests applied for cytotoxicity evaluation of compounds from the group of polyphenols","volume":"18","author":"Malinowski","year":"2022","journal-title":"Environment Sci Proceedings"},{"key":"10.1016\/j.ajps.2025.101040_bib0120","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1038\/s41598-018-19897-8","article-title":"Nanoparticle properties modulate their attachment and effect on carrier red blood cells","volume":"8","author":"Pan","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajps.2025.101040_bib0121","doi-asserted-by":"crossref","first-page":"17359","DOI":"10.1039\/D1NR04057J","article-title":"A numerical study on drug delivery via multiscale synergy of cellular hitchhiking onto red blood cells","volume":"13","author":"Nikfar","year":"2021","journal-title":"Nanoscale"},{"key":"10.1016\/j.ajps.2025.101040_bib0122","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1039\/C2SM06391C","article-title":"Influence of red blood cells on nanoparticle targeted delivery in microcirculation","volume":"8","author":"Tan","year":"2012","journal-title":"Soft Matter"},{"key":"10.1016\/j.ajps.2025.101040_bib0123","doi-asserted-by":"crossref","first-page":"4871","DOI":"10.1038\/srep04871","article-title":"Margination of micro- and nano-particles in blood flow and its effect on drug delivery","volume":"4","author":"M\u00fcller","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajps.2025.101040_bib0124","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1083\/jcb.201512020","article-title":"Peroxisomes move by hitchhiking on early endosomes using the novel linker protein PxdA","volume":"212","author":"Salogiannis","year":"2016","journal-title":"J Cell Biol"},{"key":"10.1016\/j.ajps.2025.101040_bib0125","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1021\/acs.bioconjchem.1c00479","article-title":"Surface modification of nanoparticles enhances drug delivery to the brain and improves survival in a glioblastoma multiforme murine model","volume":"33","author":"Wiwatchaitawee","year":"2022","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.ajps.2025.101040_bib0126","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1007\/s13346-022-01149-y","article-title":"Cell-based carrier for targeted hitchhiking delivery","volume":"12","author":"Liu","year":"2022","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.ajps.2025.101040_bib0127","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jconrel.2016.03.031","article-title":"Nanobiotechnology-based delivery strategies: new frontiers in brain tumor targeted therapies","volume":"240","author":"Mangraviti","year":"2016","journal-title":"J Controlled Rel"},{"key":"10.1016\/j.ajps.2025.101040_bib0128","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s40478-021-01156-z","article-title":"Macrophages and microglia: the cerberus of glioblastoma","volume":"9","author":"Buonfiglioli","year":"2021","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.ajps.2025.101040_bib0129","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/s41593-020-00789-y","article-title":"Single-cell profiling of myeloid cells in glioblastoma across species and disease stage reveals macrophage competition and specialization","volume":"24","author":"Pombo","year":"2021","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.ajps.2025.101040_bib0130","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1158\/1078-0432.CCR-18-1627","article-title":"Brain tumor microenvironment and host state: implications for immunotherapy","volume":"25","author":"Tomaszewski","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajps.2025.101040_bib0131","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.3390\/ijms23094562","article-title":"Crosstalk between \u03b2-catenin and CCL2 drives migration of monocytes towards glioblastoma cells","volume":"23","author":"Aretz","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajps.2025.101040_bib0132","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.3389\/fimmu.2019.02759","article-title":"More than just attractive: how CCL2 influences myeloid cell behavior beyond chemotaxis","volume":"10","author":"Gschwandtner","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajps.2025.101040_bib0133","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1158\/2326-6066.CIR-18-0633","article-title":"CCR2-dependent recruitment of tregs and monocytes following radiotherapy is associated with TNF\u03b1-mediated resistance","volume":"7","author":"Mondini","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.ajps.2025.101040_bib0134","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.3389\/fimmu.2018.02629","article-title":"Targeting macrophage-recruiting chemokines as a novel therapeutic strategy to prevent the progression of solid tumors","volume":"9","author":"Argyle","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajps.2025.101040_bib0135","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.2147\/IJN.S421173","article-title":"Macrophages as promising carriers for nanoparticle delivery in anticancer therapy","volume":"18","author":"Wr\u00f3blewska","year":"2023","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.ajps.2025.101040_bib0136","doi-asserted-by":"crossref","first-page":"56825","DOI":"10.1021\/acsami.1c12406","article-title":"Macrophage-mediated porous magnetic nanoparticles for multimodal imaging and postoperative photothermal therapy of gliomas","volume":"13","author":"Wang","year":"2021","journal-title":"ACS Appl Mater Interfaces"},{"issue":"JUL","key":"10.1016\/j.ajps.2025.101040_bib0137","first-page":"55043","article-title":"Macrophages and chemokines as mediators of angiogenesis","volume":"4","author":"Owen","year":"2013","journal-title":"Front Physiol"},{"key":"10.1016\/j.ajps.2025.101040_bib0138","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jconrel.2015.12.014","article-title":"Drug delivery to macrophages: challenges and opportunities","volume":"240","author":"Pei","year":"2016","journal-title":"J Controlled Rel"},{"key":"10.1016\/j.ajps.2025.101040_bib0139","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.neuron.2014.07.027","article-title":"TNF and increased intracellular iron alter macrophage polarization to a detrimental M1 phenotype in the injured spinal cord","volume":"83","author":"Kroner","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.ajps.2025.101040_bib0140","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jconrel.2013.11.001","article-title":"Polymeric nanoparticle system to target activated microglia\/macrophages in spinal cord injury","volume":"174","author":"Papa","year":"2014","journal-title":"J Controlled Rel"},{"key":"10.1016\/j.ajps.2025.101040_bib0141","doi-asserted-by":"crossref","first-page":"13","DOI":"10.12703\/P6-13","article-title":"The M1 and M2 paradigm of macrophage activation: time for reassessment","volume":"6","author":"Martinez","year":"2014","journal-title":"F1000Prime Rep"},{"key":"10.1016\/j.ajps.2025.101040_bib0142","series-title":"Interleukin 12:antitumor activity and immunotherapeutic potential in oncology","first-page":"1","volume":"1","author":"Lasek","year":"2016"},{"key":"10.1016\/j.ajps.2025.101040_bib0143","doi-asserted-by":"crossref","first-page":"37081","DOI":"10.18632\/oncotarget.9464","article-title":"Exploiting macrophages as targeted carrier to guide nanoparticles into glioma","volume":"7","author":"Pang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ajps.2025.101040_bib0144","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3390\/cells10030621","article-title":"Cancer stem cells: significance in origin, pathogenesis and treatment of glioblastoma","volume":"10","author":"Biserova","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ajps.2025.101040_bib0145","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1016\/j.celrep.2016.10.052","article-title":"Macrophage ontogeny underlies differences in tumor-specific education in brain malignancies","volume":"17","author":"Bowman","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.ajps.2025.101040_bib0146","doi-asserted-by":"crossref","first-page":"17627","DOI":"10.1021\/acsami.3c00468","article-title":"Immunostimulant in situ fibrin gel for post-operative glioblastoma treatment by macrophage reprogramming and photo\u2013chemo-immunotherapy","volume":"15","author":"Zhang","year":"2023","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.ajps.2025.101040_bib0147","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.3389\/fonc.2019.01370","article-title":"Role of matrix metalloproteinases in angiogenesis and cancer","volume":"9","author":"Quintero-Fabi\u00e1n","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.ajps.2025.101040_bib0148","doi-asserted-by":"crossref","first-page":"e1567","DOI":"10.1038\/cddis.2014.521","article-title":"Hypoxia-cultured human adipose-derived mesenchymal stem cells are non-oncogenic and have enhanced viability, motility, and tropism to brain cancer","volume":"5","author":"Feng","year":"2014","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.ajps.2025.101040_bib0149","doi-asserted-by":"crossref","first-page":"e58198","DOI":"10.1371\/journal.pone.0058198","article-title":"Mesenchymal stem cells derived from adipose tissue vs bone marrow: In vitro comparison of their tropism towards gliomas","volume":"8","author":"Pendleton","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ajps.2025.101040_bib0150","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/mt.2009.265","article-title":"Adipose-derived stem cells as therapeutic delivery vehicles of an oncolytic virus for glioblastoma","volume":"18","author":"Josiah","year":"2010","journal-title":"Molecular Ther"},{"issue":"6","key":"10.1016\/j.ajps.2025.101040_bib0151","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129292","article-title":"Human adipose tissue-derived mesenchymal stem cells target brain tumor-initiating cells","volume":"10","author":"Choi","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ajps.2025.101040_bib0152","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1479-5876-6-80","article-title":"Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells","volume":"6","author":"Sarin","year":"2008","journal-title":"J Transl Med"},{"key":"10.1016\/j.ajps.2025.101040_bib0153","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1517\/17425240903167942","article-title":"New strategies to deliver anticancer drugs to brain tumors","volume":"6","author":"Laquintana","year":"2009","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.ajps.2025.101040_bib0154","article-title":"Neutrophils in glioma microenvironment: from immune function to immunotherapy","volume":"15","author":"Sun","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajps.2025.101040_bib0155","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.701383","article-title":"Roles of neutrophils in glioma and brain metastases","volume":"12","author":"Lin","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajps.2025.101040_bib0156","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.1038\/s41467-018-07250-6","article-title":"MR imaging tracking of inflammation-activatable engineered neutrophils for targeted therapy of surgically treated glioma","volume":"9","author":"Wu","year":"2018","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.ajps.2025.101040_bib0157","doi-asserted-by":"crossref","first-page":"e1029","DOI":"10.1212\/WNL.0000000000007035","article-title":"The prevalence of MS in the United States: a population-based estimate using health claims data","volume":"92","author":"Wallin","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.ajps.2025.101040_bib0158","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/smll.201100001","article-title":"Cellular uptake, intracellular trafficking, and cytotoxicity of nanomaterials","volume":"7","author":"Zhao","year":"2011","journal-title":"Small"},{"key":"10.1016\/j.ajps.2025.101040_bib0159","doi-asserted-by":"crossref","first-page":"5731","DOI":"10.1021\/acs.nanolett.3c01484","article-title":"In situ albumin-hitchhiking NIR-II probes for accurate detection of micrometastases","volume":"23","author":"Xu","year":"2023","journal-title":"Nano Lett"},{"issue":"17","key":"10.1016\/j.ajps.2025.101040_bib0160","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2221535120","article-title":"A backpack-based myeloid cell therapy for multiple sclerosis","volume":"120","author":"Kapate","year":"2023","journal-title":"Proceed Natl Acad Sci"},{"key":"10.1016\/j.ajps.2025.101040_bib0161","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119987","article-title":"Targeted immunomodulation of inflammatory monocytes across the blood-brain barrier by curcumin-loaded nanoparticles delays the progression of experimental autoimmune encephalomyelitis","volume":"245","author":"Lu","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.ajps.2025.101040_bib0162","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10717544.2019.1701141","article-title":"Neutrophils, as \u201cTrojan horses\u201d, participate in the delivery of therapeutical PLGA nanoparticles into a tumor based on the chemotactic effect","volume":"27","author":"Hao","year":"2020","journal-title":"Drug Deliv"},{"key":"10.1016\/j.ajps.2025.101040_bib0163","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/10739680802350104","article-title":"Neutrophil adhesion and activation under flow","volume":"16","author":"Zarbock","year":"2009","journal-title":"Microcirculation"},{"key":"10.1016\/j.ajps.2025.101040_bib0164","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1476-5381.2008.00021.x","article-title":"P-selectin glycoprotein-ligand-1 regulates pulmonary recruitment of neutrophils in a platelet-independent manner in abdominal sepsis","volume":"156","author":"Asaduzzaman","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ajps.2025.101040_bib0165","article-title":"Nanocarrier-based drug delivery via cell-hitchhiking: emphasizing pharmacokinetic perspective towards taming the \u201cbig-old\u201d tumors","volume":"89","author":"Famta","year":"2023","journal-title":"J Drug Deliv Sci Technol"},{"issue":"22","key":"10.1016\/j.ajps.2025.101040_bib0166","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201706245","article-title":"Neutrophil-based drug delivery systems","volume":"30","author":"Chu","year":"2018","journal-title":"Adv Mater"},{"key":"10.1016\/j.ajps.2025.101040_bib0167","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122724","article-title":"Cell-liposome delivery system based on neuroinflammation to target the amygdala for ameliorating depressive-like behaviors","volume":"637","author":"Zhou","year":"2023","journal-title":"Int J Pharm"},{"key":"10.1016\/j.ajps.2025.101040_bib0168","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1164\/rccm.201101-0004OC","article-title":"Activation of CXCR2 by extracellular matrix degradation product acetylated Pro-Gly-Pro has therapeutic effects against sepsis","volume":"184","author":"Kim","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ajps.2025.101040_bib0169","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.apsb.2017.11.012","article-title":"Surface modification of PGP for a neutrophil\u2013nanoparticle co-vehicle to enhance the anti-depressant effect of baicalein","volume":"8","author":"Chen","year":"2018","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.ajps.2025.101040_bib0170","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.7150\/thno.19979","article-title":"Direct macromolecular drug delivery to cerebral ischemia area using neutrophil-mediated nanoparticles","volume":"7","author":"Zhang","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.ajps.2025.101040_bib0171","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/mp.2013.137","article-title":"Role of brain transmigrating neutrophils in depression-like behavior during systemic infection","volume":"19","author":"Aguliar-Valles","year":"2014","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.ajps.2025.101040_bib0172","doi-asserted-by":"crossref","first-page":"6519","DOI":"10.1021\/acsnano.2c11865","article-title":"Cryo-shocked platelet coupled with ROS-responsive nanomedicine for targeted treatment of thromboembolic disease","volume":"17","author":"Quan","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.ajps.2025.101040_bib0173","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202004381","article-title":"Neutrophil delivered hollow titania covered persistent luminescent nanosensitizer for ultrosound augmented chemo\/immuno glioblastoma therapy","volume":"8","author":"Li","year":"2021","journal-title":"Adv Sci"},{"key":"10.1016\/j.ajps.2025.101040_bib0174","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119987","article-title":"Targeted immunomodulation of inflammatory monocytes across the blood-brain barrier by curcumin-loaded nanoparticles delays the progression of experimental autoimmune encephalomyelitis","volume":"245","author":"Lu","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.ajps.2025.101040_bib0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123069","article-title":"Cellular drug delivery system for disease treatment","volume":"641","author":"Wang","year":"2023","journal-title":"Int J Pharm"},{"issue":"24","key":"10.1016\/j.ajps.2025.101040_bib0176","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202201013","article-title":"A living material constructed from stem cells for tumor-tropic oncotherapy with real-time imaging","volume":"32","author":"Hao","year":"2022","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.ajps.2025.101040_bib0177","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1080\/10717544.2022.2053762","article-title":"Platelets are highly efficient and efficacious carriers for tumor-targeted nano-drug delivery","volume":"29","author":"Li","year":"2022","journal-title":"Drug Deliv"}],"container-title":["Asian Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S181808762500025X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S181808762500025X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T23:40:21Z","timestamp":1762558821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S181808762500025X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":177,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S181808762500025X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajps.2025.101040","relation":{},"ISSN":["1818-0876"],"issn-type":[{"value":"1818-0876","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Navigating the brain: Harnessing endogenous cellular hitchhiking for targeting neoplastic and neuroinflammatory diseases","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajps.2025.101040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Shenyang Pharmaceutical University. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101040"}}